Trial Profile
Clinical efficacy and safety of NAI-Acne gel 3% applied twice-a-day to patients with facial acne vulgaris
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Mar 2017
Price :
$35
*
At a glance
- Drugs NAI-Acne (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors NAICONS
- 25 Mar 2017 This trial has been completed in Slovakia (end date:11-dec-2015), according to European Clinical Trials Database.
- 30 Mar 2015 New trial record